เอกสารอ้างอิง
[1] May RJ and Smith PH. Allergic rhinitis: Therapeutic Considerations. In, Dipiro JT, et al. Pharmacotherapy: a pathophysiologic Approach. 9th ed. Newyork: McGRAW-Hill companies; 2014. P.813-20
[2] Dykewicz MS, Kaliner MA. Rhinitis medicamentosa treatment and management [Internet]. New York: WebMD; c1994-2009 [updated 2018 Jan 2; cited 2020 May 23] Available from: https://emedicine.medscape.com/article/995056-treatment
[3] Shah SB, Emanuel IA. Nonallergic and Allergic Rhinitis. In: Lalwani AK. eds. Current Diagnosis & Treatment Otolaryngology—Head and Neck Surgery, 14th ed New York, NY: McGraw-Hill; 2014. [Accessed 2020 May 23] Available from: http://accessmedicine.mhmedical.com/content.aspx?bookid=2744§ionid=229671736.
[4] O’Handley JG, Tobin EJ Shah AR. Otorhinolaryngology. In: Rakel RE. eds. Textbook of family medicine, 9th ed Amsterdam: ELSEVIER; 2015. [Accessed 2020 May 23] Available from: https://www.clinicalkey.com/#!/content/book/3-s2.0-B9780323239905000186?scrollTo=%23hl0002354
[5] Liberman PL, Corren J. Chronic nonallergic rhinitis [Internet]. Waltham (MA): UpToDate; 2014 [updated 2020 Jan 6; cited 2020 May 23] Available from: https://www.uptodate.com
[6] Jonathan MZ. Budesonide, Beclomethasone, Fluticasone. In: UpToDate, Post TW(Ed), UpToDate, Waltham, MA. (Accessed on 2020 May 24)
[7] Graf P. Rhinitis medicamentosa: a review of causes and treatment. Treat Respir Med. 2005;4(1):21‐29. doi:10.2165/00151829-200504010-00003
[8] Vaidyanathan S, Williamson P, Clearie K, Khan F, Lipworth B. Fluticasone reverses oxymetazoline-induced tachyphylaxis of response and rebound congestion. American journal of respiratory and critical care medicine. 2010;182(1):19‐24. doi:10.1164/rccm.200911-1701OC